July 1, 2014 | The developer of the ReWalk exoskeleton, Argo Medical Technologies, will attempt to raise $40-50 million on Nasdaq at a company value of $250-300 million, according to a “Globes” report. Earlier this week, the ReWalk exoskeleton, designed to help paraplegics and quadriplegics usually confined to wheelchairs walk again, was approved by the Food & Drug Administration (FDA) in the United States for use at home and in the community. Argo Medical Technologies was founded by Dr. Amit Goffer in 2001 and quickly grew from a small startup based in Israel to an international company with offices in the US, Germany and Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments